CCFA Co-Funds IBD Research in Partnership with Pfizer’s Centers for Therapeutic Innovation

CCFA Co-Funds IBD Research in Partnership with Pfizer’s Centers for Therapeutic Innovation
The Crohn’s & Colitis Foundation of America (CCFA) and Pfizer’s Centers for Therapeutic Innovation (CTI) have signed an agreement to support potential development and translational research projects for inflammatory bowel disease (IBD). The partnership will feature capital support from CCFA and the field experience of CTI’s academic medical centers. This is the first alliance that the CCFA has established

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *